A method for synthesizing 5-methoxytryptamine, a key intermediate in melatonin production.

By using the improved Fischer indole synthesis method, an indole core was directly constructed from 4-methoxyphenylhydrazine salt and 2,3-dihydrofuran, avoiding the diazotization reaction. This solved the safety and efficiency problems of 5-methoxytryptamine synthesis and enabled high-yield and low-cost industrial production.

CN123106508APending Publication Date: 2026-11-17BEIJING RUIQI BIOMEDICAL TECH CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202611277060.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2025-08-22
Filing Date
2026-08-21
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

The existing synthesis process of 5-methoxytryptamine is complicated, dangerous, and costly, and is not suitable for industrial production. In particular, the diazotization reaction poses safety hazards and uses highly toxic, flammable and explosive raw materials.

Method used

The Fischer indole synthesis reaction was carried out using 4-methoxyphenylhydrazine salt and 2,3-dihydrofuran, avoiding the diazotization step, and 5-methoxytryptamine was prepared through a multi-step reaction, including the direct construction of intermediates, esterification and hydrolysis, using safe and mild reaction conditions.

Benefits of technology

It significantly improves safety and reaction yield, simplifies the process, reduces production costs, avoids the use of hazardous raw materials, and is suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123106508A_ABST
    Figure CN123106508A_ABST
Patent Text Reader

Abstract

This invention provides a method for synthesizing 5-methoxytryptamine, a key intermediate in melatonin production. The method includes the following steps: using 4-methoxyphenylhydrazine salt and 2,3-dihydrofuran as raw materials, 5-methoxytryptamine is prepared via a Fischer indole synthesis reaction to obtain 5-methoxytryptamine, intermediate 1; intermediate 1 is reacted with p-toluenesulfonyl chloride in the presence of an acid-binding agent to obtain a p-toluenesulfonate ester of 5-methoxytryptamine, intermediate 2; intermediate 2 is reacted with phthalimide or its salt in an aprotic polar solvent to obtain N-(2-(5-methoxy-1H-indole-3-yl)ethyl)phthalimide, intermediate 3; intermediate 3 is hydrolyzed under alkaline conditions, simultaneously removing the p-toluenesulfonyl group and the phthalimide group to obtain 5-methoxytryptamine. This method avoids the diazotization reaction unit, greatly reducing safety risks, improving the yield of the Fischer indole cyclization reaction, and is simple to operate, suitable for industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of drug synthesis technology, and specifically relates to a method for synthesizing 5-methoxytryptamine, a key intermediate of melatonin. Background Technology

[0002] 5-Methoxytryptamine is an important intermediate in the synthesis of many drugs. For example, melatonin (MT) is a hormone secreted by the pineal gland in the brain, and its chemical name is N-acetyl-5-methoxytryptamine. Melatonin plays a significant role in regulating circadian rhythms, inhibiting sex hormone secretion, enhancing neuroendocrine-immune regulation, and antioxidation. Therefore, the research and application of 5-methoxytryptamine in the pharmaceutical field are of great significance.

[0003] Because 5-methoxytryptamine contains active functional groups such as an indole ring and an amino group, it can participate in a variety of organic synthetic reactions, such as substitution reactions, addition reactions, and condensation reactions. These reactions provide rich possibilities and flexibility for synthesizing compounds with specific structures and functions. Therefore, 5-methoxytryptamine has important applications in organic synthetic chemistry.

[0004] There are different processes for the preparation of 5-methoxytryptamine: Patent CN110818610A mentions that 5-methoxytryptamine is prepared by a three-step reaction of carbon-nitrogen coupling, cyclization, hydrolysis and decarboxylation, starting from phthalimide. The process of this patent is complicated, involves many types of raw materials, and uses 1,3-dichloropropane, which is harmful to the human body.

[0005] CN110229092A describes the synthesis of 5-methoxyindole as a starting material, which involves acylation with phosgene, dechlorination and amination, followed by reduction with lithium aluminum hydride to 5-methoxytryptamine. The synthesis of 5-methoxytryptamine involves complex procedures and harsh reaction conditions. The raw materials and reagents used are highly harmful to the environment, and the use of highly toxic substances such as phosgene and phosgene and flammable and explosive substances such as lithium aluminum hydride makes it unsuitable for industrial production.

[0006] CN113214133A uses 5-hydroxytryptamine hydrochloride as a raw material and obtains 5-methoxytryptamine through a one-pot feeding method via hydroxyl methylation. 5-hydroxytryptamine has a relatively high cost, and methylation of 5-hydroxytryptamine will cause methylation of the N atom at the 1-position of indole and methylation of the primary amine in the side chain, resulting in more side reactions.

[0007] J Org Chem, 1960, 25(2):857-859 reported that 5-methoxytryptamine was obtained by reacting 4-methoxyphenylhydrazine with 4-chlorobutanal via a fishcer reaction. Although 4-chlorobutanal is commercially available, its purity is generally low and its stability is poor. As a result, the yield of the process is low, the product is difficult to purify, and it does not have industrial value.

[0008] In EP330625, a reaction route using simple starting materials was designed based on the Japp-Klingemann reaction. Wang Jiawang et al. (Fine Chemicals, 1999, 16(2), 16-19) simplified and improved this method, designing a four-step synthesis method using potassium phthalimide as the starting material. The synthesis route is as follows:

[0009] Although this reaction improves the yield of the fishcer cyclization reaction, the process involves a diazotization step, which is highly dangerous and not conducive to industrial production. Summary of the Invention

[0010] In view of the problems existing in the prior art, the purpose of this invention is to provide a method for synthesizing 5-methoxytryptamine, a key intermediate of melatonin.

[0011] The objective of this invention is achieved through the following technical solution: In a first aspect, the present invention provides a method for synthesizing 5-methoxytryptamine, a key intermediate in melatonin production, comprising the following steps: (1) Using 4-methoxyphenylhydrazine salt and 2,3-dihydrofuran as raw materials, 5-methoxychromol was prepared by Fischer indole synthesis reaction, which is intermediate 1; (2) The intermediate 1 obtained in step (1) is reacted with p-toluenesulfonyl chloride in the presence of an acid-binding agent to obtain p-toluenesulfonate of 5-methoxychromol, which is intermediate 2; (3) The p-toluenesulfonate group of intermediate 2 obtained in step (2) is reacted with phthalimide or its salt in an aprotic polar solvent to obtain N-(2-(5-methoxy-1H-indol-3-yl)ethyl)phthalimide, which is intermediate 3; (4) The intermediate 3 obtained in step (3) is hydrolyzed under alkaline conditions to remove p-toluenesulfonyl group and phthalimide group, thereby obtaining the 5-methoxytryptamine.

[0012] The synthesis steps are as follows:

[0013]

[0014]

[0015] .

[0016] Furthermore, in step (1), the Fischer indole synthesis reaction is carried out under acidic conditions, which are provided by dilute sulfuric acid.

[0017] Furthermore, in step (1), the Fischer indole synthesis reaction is carried out in an aprotic polar solvent selected from N,N-dimethylacetamide or acetonitrile.

[0018] Furthermore, in step (1), the temperature of the Fischer indole synthesis reaction is 90℃~100℃.

[0019] Furthermore, in step (2), the reaction is carried out in a nonpolar solvent selected from dichloromethane, chloroform, ethyl acetate, tetrahydrofuran, or toluene.

[0020] Furthermore, in step (2), the molar ratio of intermediate 1 to p-toluenesulfonyl chloride is 1:0.9~3.0; the acid-binding agent is selected from inorganic bases or organic bases, the inorganic base is selected from sodium hydroxide or potassium hydroxide, and the organic base is selected from triethylamine or tri-n-butylamine; the reaction temperature is 0℃~30℃.

[0021] Furthermore, in step (3), the aprotic polar solvent is selected from N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide or acetonitrile; the reaction temperature is 8℃~100℃.

[0022] Furthermore, in step (4), the alkaline conditions are provided by an alkaline aqueous solution, which is selected from sodium hydroxide aqueous solution, potassium hydroxide aqueous solution or lithium hydroxide aqueous solution.

[0023] Furthermore, in step (4), the reaction temperature is 80℃~100℃; the molar ratio of the N-(2-(5-methoxy-1H-indol-3-yl)ethyl)phthalimide to the base is 1:3~10.

[0024] In a second aspect, the present invention provides 5-methoxytryptamine synthesized by the method of the first aspect.

[0025] The advantages of this invention compared to the prior art are as follows: 1. Significantly improved security This invention avoids the diazotization reaction unit in traditional processes. In existing technologies, the synthesis of 5-methoxytryptamine from potassium phthalimide via the Japp-Klingemann reaction involves a diazotization reaction, which is inconvenient to operate, poses an explosion hazard, and presents significant safety risks, hindering industrial production. This invention, by directly reacting 4-methoxyphenylhydrazine with 2,3-dihydrofuran via a modified Fischer indole reaction, fundamentally avoids the diazotization step, greatly reducing safety risks during production. 2. The reaction yield was significantly improved. This invention employs a modified Fischer indole synthesis method, directly constructing an indole core from 4-methoxyphenylhydrazine salt and 2,3-dihydrofuran. Compared to the traditional Fischer indole synthesis process, this significantly improves the reaction yield for preparing the indole core. Example data shows that the yield of 5-methoxytryptamine in step (1) can reach 80% or 72%. After the subsequent three steps, the final total yield of 5-methoxytryptamine is excellent, fully demonstrating the high efficiency of the method of this invention. 3. Simplified process operation and shortened cycle time The method of this invention has simple reaction steps, mild reaction conditions in each step, and is easy to operate. The crude 5-methoxychromol obtained in step (1) can be used directly in the next reaction without purification, eliminating the purification step of intermediates, shortening the process cycle, reducing production costs, and making it more suitable for large-scale industrial production; 4. Avoids the use of hazardous raw materials The method of this invention does not require the use of highly toxic or flammable and explosive hazardous raw materials such as phosgene and lithium aluminum hydride, thus avoiding the environmental and safety risks associated with the use of phosgene carbonyl chloride and lithium aluminum hydride in the prior art CN110229092A, making the reaction process more green and environmentally friendly. Attached Figure Description

[0026] The present invention will be further described below with reference to the accompanying drawings and embodiments: Figure 1 The 1H NMR spectrum of intermediate 2; Figure 2 The 1H NMR spectrum of intermediate 3; Figure 3 The 1H NMR spectrum of 5-methoxytryptamine. Detailed Implementation

[0027] The embodiments described are provided to better illustrate the present invention, but are not intended to limit the scope of the invention to the embodiments described. Therefore, non-essential improvements and adjustments made to the embodiments by those skilled in the art based on the above description are still within the scope of protection of the present invention.

[0028] The endpoints and any values ​​of the ranges disclosed herein are not limited to the precise ranges or values, and these ranges or values ​​should be understood to include values ​​close to these ranges or values. For numerical ranges, the endpoint values ​​of the various ranges, the endpoint values ​​of the various ranges and individual point values, and individual point values ​​can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed herein.

[0029] The present invention will be described in detail below through embodiments. It should be understood that the following embodiments are only used to exemplify and further explain and illustrate the content of the present invention, and are not intended to limit the present invention.

[0030] This invention provides a method for synthesizing 5-methoxytryptamine, a key intermediate in melatonin production, specifically comprising the following steps: (1) 5-methoxychromol was prepared by Fischer indole synthesis reaction using 4-methoxyphenylhydrazine salt and 2,3-dihydrofuran as raw materials. It is intermediate 1.

[0031] (2) The intermediate 1 obtained in step (1) is reacted with p-toluenesulfonyl chloride in the presence of an acid-binding agent to obtain p-toluenesulfonate of 5-methoxychromol, which is intermediate 2. Figure 1 The 1H NMR spectrum of intermediate 2 is shown.

[0032] (3) The p-toluenesulfonate group of intermediate 2 obtained in step (2) is reacted with phthalimide or its salt in an aprotic polar solvent to obtain N-(2-(5-methoxy-1H-indole-3-yl)ethyl)phthalimide, which is intermediate 3. Figure 2 The 1H NMR spectrum of intermediate 3 is shown.

[0033] (4) The intermediate 3 obtained in step (3) is hydrolyzed under alkaline conditions to remove p-toluenesulfonyl group and phthalimide group, thereby obtaining the 5-methoxytryptamine. Figure 3 The 1H NMR spectrum of 5-methoxytryptamine is shown.

[0034] According to some preferred embodiments of the present invention, in step (1), the Fischer indole synthesis reaction is carried out under acidic conditions, wherein the acidic conditions are provided by dilute sulfuric acid.

[0035] According to some preferred embodiments of the present invention, in step (1), the Fischer indole synthesis reaction is carried out in an aprotic polar solvent selected from N,N-dimethylacetamide or acetonitrile.

[0036] According to some specific embodiments of the present invention, in step (1), the temperature of the Fischer indole synthesis reaction is 90℃~100℃.

[0037] According to some preferred embodiments of the present invention, in step (2), the reaction is carried out in a nonpolar solvent selected from dichloromethane, chloroform, ethyl acetate, tetrahydrofuran or toluene.

[0038] According to some preferred embodiments of the present invention, in step (2), the molar ratio of intermediate 1 to p-toluenesulfonyl chloride is 1:0.9~3.0; the acid-binding agent is selected from inorganic bases or organic bases, the inorganic base is selected from sodium hydroxide or potassium hydroxide, and the organic base is selected from triethylamine or tri-n-butylamine; the reaction temperature is 0℃~30℃.

[0039] According to some preferred embodiments of the present invention, in step (3), the aprotic polar solvent is selected from N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide or acetonitrile; the reaction temperature is 8℃~100℃.

[0040] According to some preferred embodiments of the present invention, in step (4), the alkaline conditions are provided by an alkaline aqueous solution, which is selected from sodium hydroxide aqueous solution, potassium hydroxide aqueous solution or lithium hydroxide aqueous solution.

[0041] According to some preferred embodiments of the present invention, in step (4), the reaction temperature is 80℃~100℃; the molar ratio of N-(2-(5-methoxy-1H-indole-3-yl)ethyl)phthalimide to the base is 1:3~10.

[0042] Example 1 This embodiment provides a method for synthesizing 5-methoxytryptamine, a key intermediate in melatonin production, specifically including the following steps: Add 200g of prepared 4% sulfuric acid aqueous solution to a 1000ml three-necked flask, add 100ml of DMA, and add 100g of 4-methoxyphenylhydrazine hydrochloride. Heat to an internal temperature of 80-90℃, then add 2,3-dihydrofuran dropwise. Maintain the temperature at 90-100℃ until the reaction is complete. After the reaction is complete, cool to room temperature, extract twice with ethyl acetate, and use saturated... The pH of the aqueous solution was adjusted to neutral, dried over anhydrous sodium sulfate, and concentrated to dryness to obtain 88 g of crude 5-methoxychromol intermediate, a reddish-brown oily substance with a yield of 80%. It can be used directly in the next reaction without further purification.

[0043] 150 g of p-toluenesulfonyl chloride and 450 ml of DCM were added to a 1000 ml three-necked flask. 57 g of sodium hydroxide was added and stirred. 88 g of a DCM solution of 5-methoxychromol was added dropwise while maintaining the temperature at 10-20 °C. After the addition was complete, the mixture was kept at 10-20 °C until the reaction was complete. The reaction was stopped, and the mixture was washed once with 500 ml of water, followed by once with a saturated NaCl aqueous solution. The organic phase was dried over anhydrous sodium sulfate and concentrated to dryness to obtain crude intermediate 2. The crude product was recrystallized from ethyl acetate and n-heptane to give an off-white solid, which was dried to obtain 110 g, yield: 48%.

[0044] 110 g of intermediate 2, 400 ml of DMF, and 45 g of potassium phthalimide were added to a 1000 ml three-necked flask. The mixture was stirred and heated to 100 °C until the reaction was complete. After the reaction was complete, the mixture was allowed to cool naturally, extracted twice with dichloromethane, and the dichloromethane phases were combined, washed three times with water, and concentrated to dryness under reduced pressure to obtain 60 g of off-white solid intermediate 3, with a yield of 57%.

[0045] 60 g of KOH and water were added to a 1000 ml three-necked flask to prepare a 10% aqueous solution. The catalyst and 60 g of intermediate 3 were added and refluxed until the reaction was complete. The mixture was cooled to room temperature and extracted twice with DCM. The organic phases were combined and washed once with saturated NaCl water. The organic phase was dried over anhydrous sodium sulfate and concentrated to dryness. The mixture was recrystallized with a mixed solvent of ethyl acetate and n-heptane to give 21 g of 5-methoxytryptamine, with a yield of 87%.

[0046] Example 2 This embodiment provides a method for synthesizing 5-methoxytryptamine, a key intermediate in melatonin production, specifically including the following steps: Add 200g of prepared 4% sulfuric acid aqueous solution to a 1000ml three-necked flask, then add 100ml of acetonitrile and 100g of 4-methoxyphenylhydrazine hydrochloride. Heat to an internal temperature of 80-90℃, then add 2,3-dihydrofuran dropwise. Maintain the temperature at 90-100℃ until the reaction is complete. After the reaction is complete, cool to room temperature, extract twice with ethyl acetate, and use saturated... The pH of the aqueous solution was adjusted to neutral, dried over anhydrous sodium sulfate, and concentrated to dryness to give 79 g of crude 5-methoxychromol intermediate, a reddish-brown oily substance with a yield of 72%. It can be used directly in the next reaction without further purification.

[0047] 150 g of p-toluenesulfonyl chloride and 450 ml of DCM were added to a 1000 ml three-necked flask. 50 g of sodium hydroxide was added and stirred. 79 g of a DCM solution of 5-methoxychromol was added dropwise while maintaining the temperature at 20-30 °C. After the addition was complete, the mixture was kept at 20-30 °C until the reaction was complete. The reaction was stopped, and the mixture was washed once with 500 ml of water, followed by once with a saturated NaCl aqueous solution. The organic phase was dried over anhydrous sodium sulfate and concentrated to dryness to obtain crude intermediate 2. The crude product was recrystallized from ethyl acetate and n-heptane to give an off-white solid, which was dried to obtain 112 g, yield: 54%.

[0048] 110 g of intermediate 2, 400 ml of DMA, and 45 g of potassium phthalimide were added to a 1000 ml three-necked flask. The mixture was stirred and heated to 100 °C until the reaction was complete. After the reaction was complete, the mixture was allowed to cool naturally, extracted twice with dichloromethane, and the dichloromethane phases were combined, washed three times with water, and concentrated to dryness under reduced pressure to obtain 62 g of off-white solid intermediate 3, with a yield of 59%.

[0049] 70 g of KOH and water were added to a 1000 ml three-necked flask to prepare a 10% aqueous solution. The catalyst and 60 g of intermediate 3 were added and refluxed until the reaction was complete. The mixture was cooled to room temperature and extracted twice with DCM. The organic phases were combined and washed once with saturated NaCl water. The organic phase was dried over anhydrous sodium sulfate and concentrated to dryness. The mixture was recrystallized with a mixed solvent of ethyl acetate and n-heptane to give 23 g of 5-methoxytryptamine, with a yield of 95%.

[0050] Finally, it should be noted that the above description is only used to illustrate the technical solutions of the present invention and is not intended to limit it. Although the present invention has been described in detail with reference to preferred embodiments, those skilled in the art should understand that modifications or equivalent substitutions can be made to the technical solutions of the present invention without departing from the spirit and scope of the present invention.

Claims

1. A method for synthesizing 5-methoxytryptamine, a key intermediate in melatonin production, characterized in that, The synthesis method includes the following steps: (1) Using 4-methoxyphenylhydrazine salt and 2,3-dihydrofuran as raw materials, 5-methoxychromol was prepared by Fischer indole synthesis reaction, which is intermediate 1; (2) The intermediate 1 obtained in step (1) is reacted with p-toluenesulfonyl chloride in the presence of an acid-binding agent to obtain p-toluenesulfonate of 5-methoxychromol, which is intermediate 2; (3) The p-toluenesulfonate group of intermediate 2 obtained in step (2) is reacted with phthalimide or its salt in an aprotic polar solvent to obtain N-(2-(5-methoxy-1H-indol-3-yl)ethyl)phthalimide, which is intermediate 3; (4) The intermediate 3 obtained in step (3) is hydrolyzed under alkaline conditions to remove p-toluenesulfonyl group and phthalimide group, thereby obtaining the 5-methoxytryptamine.

2. The synthesis method according to claim 1, characterized in that, In step (1), the Fischer indole synthesis reaction is carried out under acidic conditions, which are provided by dilute sulfuric acid.

3. The synthesis method according to claim 1, characterized in that, In step (1), the Fischer indole synthesis reaction is carried out in an aprotic polar solvent selected from N,N-dimethylacetamide or acetonitrile.

4. The synthesis method according to claim 1, characterized in that, In step (1), the temperature of the Fischer indole synthesis reaction is 90℃~100℃.

5. The synthesis method according to claim 1, characterized in that, In step (2), the reaction is carried out in a nonpolar solvent selected from dichloromethane, chloroform, ethyl acetate, tetrahydrofuran, or toluene.

6. The synthesis method according to claim 1, characterized in that, In step (2), the molar ratio of intermediate 1 to p-toluenesulfonyl chloride is 1:0.9~3.0; the acid-binding agent is selected from inorganic bases or organic bases, the inorganic base is selected from sodium hydroxide or potassium hydroxide, and the organic base is selected from triethylamine or tri-n-butylamine; the reaction temperature is 0℃~30℃.

7. The synthesis method according to claim 1, characterized in that, In step (3), the aprotic polar solvent is selected from N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide or acetonitrile; the reaction temperature is 8℃~100℃.

8. The synthesis method according to claim 1, characterized in that, In step (4), the alkaline conditions are provided by an alkaline aqueous solution, which is selected from sodium hydroxide aqueous solution, potassium hydroxide aqueous solution or lithium hydroxide aqueous solution.

9. The synthesis method according to claim 1, characterized in that, In step (4), the reaction temperature is 80℃~100℃; the molar ratio of N-(2-(5-methoxy-1H-indol-3-yl)ethyl)phthalimide to the base is 1:3~10.

10. 5-Methoxytryptamine synthesized by any one of claims 1 to 9.

Citation Information

Patent Citations

  • Method for efficiently producing melatonin

    CN110229092A

  • Preparation method of melatonin

    CN110818610A

  • Synthesis method of melatonin

    CN113214133A

  • Total synthesis method for making an indole structure derivative product class, of the triptamine type, in particular, melatonin or N-acetyl-5-methoxytriptamine type, having a high purity degree and easily soluble, for therapeutic use against acquired immuno-deficiency syndromes

    EP0330625A2